KP-1461

KP-161 is an experimental antiviral drug being studied for the treatment of HIV/AIDS.[1] It belongs to the class of nucleoside reverse transcriptase inhibitors.

KP-1461
Clinical data
Drug classReverse transcriptase inhibitor
Legal status
Legal status
  • Investigational
Identifiers
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
Chemical and physical data
FormulaC16H23N4O6
Molar mass367.382 g·mol−1
3D model (JSmol)

KP-1461 is a prodrug of the active antiviral agent KP-1212.[2]

References

  1. "KP-1461". AIDSinfo. U.S. Department of Health and Human Services.
  2. "KP-1461". DrugBank. Canadian Institutes of Health Research.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.